← Leaderboards
Daniel M Corcos
Northwestern University
$39,212,369
Attributed
$41,874,480
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,874,480 · 8
By mechanism
U01$26,938,542 · 2
R01$14,571,938 · 5
R56$364,000 · 1
Top collaborators
- Margaret L Schenkman4 shared
- David E Vaillancourt3 shared
Most similar at Northwestern University
Same institution · by research overlap
- Erin King$87,942
- Eric J Perreault$12,904,267
- Allison Hyngstrom$3,203,559
Others in their field
Top investigators on “Motor”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Jane S Paulsen · University Of Wisconsin-Madison$53,147,245
- Jerrold L Vitek · University Of Minnesota$52,399,244
- Merit E Cudkowicz · Massachusetts General Hospital$49,510,334
- Michael M Johns · Emory University$49,234,033
- David A Bennett · Rush University Medical Center$37,162,250
Research focus
MotorParkinson DiseaseAffectPharmaceutical PreparationsBaseRandomizedDesignMovementQuality Of LifeBasal GangliaOperative Surgical ProceduresProtocols DocumentationSymptomsProgramsDoseNeurophysiologyNeuroregulationPerformanceExercisePublic HealthClinical ResearchLiteratureLevodopaLimb Structure
Grant awards (46)
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3$3,489,019
U01 · FY2025 · NS · contact PI
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3$934,400
U01 · FY2025 · NS · contact PI
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3$36,374
U01 · FY2025 · NS · contact PI
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3$1,319,925
U01 · FY2024 · NS · contact PI
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3$7,226,355
U01 · FY2023 · NS · contact PI
Bilateral Priming Plus Task Specific Training for Severe Upper Limb Hemiparesis$319,211
R01 · FY2021 · HD · contact PI
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3$7,159,125
U01 · FY2020 · NS · contact PI
Effect of Unilateral and Bilateral STN Stimulation on Eye-Hand Coordination$304,223
R01 · FY2020 · NS · contact PI
Bilateral Priming Plus Task Specific Training for Severe Upper Limb Hemiparesis$293,253
R01 · FY2020 · HD · contact PI
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3$4,442,386
U01 · FY2019 · NS · contact PI
Neuroimaging Biomarkers in Parkinsonism: Differentiating Subtypes and Tracking Disease Progression$758,698
U01 · FY2019 · NS
Effect of Unilateral and Bilateral STN Stimulation on Eye-Hand Coordination$304,223
R01 · FY2019 · NS · contact PI
Bilateral Priming Plus Task Specific Training for Severe Upper Limb Hemiparesis$293,328
R01 · FY2019 · HD · contact PI
Neuroimaging Biomarkers in Parkinsonism: Differentiating Subtypes and Tracking Disease Progression$762,717
U01 · FY2018 · NS
Effect of Unilateral and Bilateral STN Stimulation on Eye-Hand Coordination$304,223
R01 · FY2018 · NS · contact PI
Bilateral Priming Plus Task Specific Training for Severe Upper Limb Hemiparesis$298,112
R01 · FY2018 · HD · contact PI
Neuroimaging Biomarkers in Parkinsonism: Differentiating Subtypes and Tracking Disease Progression$809,543
U01 · FY2017 · NS
Bilateral Priming Plus Task Specific Training for Severe Upper Limb Hemiparesis$312,822
R01 · FY2017 · HD · contact PI
Effect of Unilateral and Bilateral STN Stimulation on Eye-Hand Coordination$307,447
R01 · FY2017 · NS · contact PI
Effect of Unilateral and Bilateral STN Stimulation on Eye-Hand Coordination$312,921
R01 · FY2016 · NS · contact PI
Exploratory study of different doses of endurance exercise in people with Parkins$727,442
R01 · FY2014 · NS
Exploratory study of different doses of endurance exercise in people with Parkins$744,317
R01 · FY2013 · NS
Exploratory study of different doses of endurance exercise in people with Parkins$746,016
R01 · FY2012 · NS
Exploratory study of different doses of endurance exercise in people with Parkins$775,490
R01 · FY2011 · NS
Motor Deficits - Experimental and Clinical Correlates$375,887
R01 · FY2011 · NS · contact PI
STN Stimulation: Neural Control of Movement and Posture$364,000
R56 · FY2011 · NS · contact PI
Motor Deficits - Experimental and Clinical Correlates$416,666
R01 · FY2010 · NS · contact PI
Motor Deficits - Experimental and Clinical Correlates$516,136
R01 · FY2009 · NS · contact PI
STN Stimulation - Neural Control of Movement and Posture$307,097
R01 · FY2009 · NS · contact PI
Motor Deficits - Experimental and Clinical Correlates$566,770
R01 · FY2008 · NS · contact PI
STN Stimulation - Neural Control of Movement and Posture$308,657
R01 · FY2008 · NS · contact PI
Motor Deficits - Experimental and Clinical Correlates$593,300
R01 · FY2007 · NS · contact PI
STN Stimulation - Neural Control of Movement and Posture$310,143
R01 · FY2007 · NS · contact PI
STN Stimulation - Neural Control of Movement and Posture$320,864
R01 · FY2006 · NS · contact PI
STN Stimulation - Neural Control of Movement and Posture$342,725
R01 · FY2005 · NS
MOTOR DEFICITS - EXPERIMENTAL AND CLINICAL CORRELATES$294,010
R01 · FY2005 · NS
STN STIMULATION--NEURAL CONTROL OF MOVEMENT AND POSTURE$631,773
R01 · FY2004 · NS
MOTOR DEFICITS - EXPERIMENTAL AND CLINICAL CORRELATES$294,010
R01 · FY2004 · NS
STN STIMULATION--NEURAL CONTROL OF MOVEMENT AND POSTURE$614,336
R01 · FY2003 · NS
MOTOR DEFICITS - EXPERIMENTAL AND CLINICAL CORRELATES$294,010
R01 · FY2003 · NS
STN STIMULATION--NEURAL CONTROL OF MOVEMENT AND POSTURE$26,680
R01 · FY2003 · NS
STN STIMULATION--NEURAL CONTROL OF MOVEMENT AND POSTURE$557,625
R01 · FY2002 · NS
MOTOR DEFICITS - EXPERIMENTAL AND CLINICAL CORRELATES$294,010
R01 · FY2002 · NS
STN STIMULATION--NEURAL CONTROL OF MOVEMENT AND POSTURE$543,381
R01 · FY2001 · NS
MOTOR DEFICITS - EXPERIMENTAL AND CLINICAL CORRELATES$358,333
R01 · FY2001 · NS
STN STIMULATION--NEURAL CONTROL OF MOVEMENT AND POSTURE$562,497
R01 · FY2000 · NS